Widely used:Recently Viewed
Clear All
$0.48
$-0.03
(-5.49%)
As on 08-Oct-2024 16:00 EDT
$2 Mln
--
0.29
94.44
0
-203.38 %
--
--
--
-10678507
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Helius Medical Technologies Inc Class A (HSDT)
| -94.00 | -45.28 | -47.93 | -94.46 | -91.06 | -82.63 | -65.11 |
|
BSE Sensex*
| 13.16 | 0.69 | 2.23 | 23.86 | 10.82 | 16.85 | 12.03 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Helius Medical Technologies Inc Class A (HSDT)
| -47.61 | -94.08 | -60.63 | -61.18 | -89.41 | -25.54 | 78.83 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 | 11.73 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Our rating system has guided millions of investors in the past 20 years.
$1.82 Mln
$0.59 Mln
$0.00 Mln
$6.39 Mln
$0.04 Mln
High
$0.45 - 9.50
3,576,200
NASDAQ: HSDT
Newtown, PA
https://heliusmedical.com
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable... Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania. Address: 642 Newtown Yardley Road, Newtown, PA, United States, 18940 Read more
The total asset value of Helius Medical Technologies Inc Class A (HSDT) stood at $ 11 Mln as on 30-Jun-24
The share price of Helius Medical Technologies Inc Class A (HSDT) is $0.48 (NASDAQ) as of 08-Oct-2024 16:00 EDT. Helius Medical Technologies Inc Class A (HSDT) has given a return of -91.06% in the last 3 years.
Helius Medical Technologies Inc Class A (HSDT) has a market capitalisation of $ 2 Mln as on 08-Oct-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Helius Medical Technologies Inc Class A (HSDT) is 0.29 times as on 08-Oct-2024, a 93% discount to its peers’ median range of 4.22 times.
Since, TTM earnings of Helius Medical Technologies Inc Class A (HSDT) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Helius Medical Technologies Inc Class A (HSDT) and enter the required number of quantities and click on buy to purchase the shares of Helius Medical Technologies Inc Class A (HSDT).
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania. Address: 642 Newtown Yardley Road, Newtown, PA, United States, 18940
The CEO & director of Mr. Dane Carl Andreeff. is Helius Medical Technologies Inc Class A (HSDT), and CFO & Sr. VP is Mr. Dane Carl Andreeff.
There is no promoter pledging in Helius Medical Technologies Inc Class A (HSDT).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,011
|
|
|
953
|
|
|
937
|
|
|
912
|
| Helius Medical Technologies Inc Class A (HSDT) | Ratios |
|---|---|
|
Return on equity(%)
|
-203.38
|
|
Operating margin(%)
|
-1889.06
|
|
Net Margin(%)
|
-1487.54
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Helius Medical Technologies Inc Class A (HSDT) was $0 Mln.
